Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this free, full length talk
Topics Covered
- Why viruses must mutate for interspecies transmission
- Overview of SARS-CoV-2 infection of cells
- Tropism of bat coronavirus RaTG13 and SARS-CoV-2
- Studying the mutations allowing interspecies transmission of the virus
- The main mutations found so far in SARS-CoV-2 allowing interspecies transmission to human
- Possibilities of cross-species transmission from humans
- More information about the study described by Dr Bailey can be found in the PLOS Biology article: ‘The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins’ https://doi.org/10.1371/journal.pbio.3001016. Of note, the mutagenesis studies using RaTG13 and SARS-CoV-2 Spike described by Dr Bailey were performed using pseudotype systems and codon-optimised Spike expression constructs. These mutations were not built into replication competent viruses.
Biography
Dr Dalan Bailey is a Group Leader working on the molecular biology of RNA viruses including human and bovine respiratory syncytial virus, the henipa- and morbilli- viruses, and more recently SARS-CoV-2. His research is particularly focused on the virus-host interactions that take place during virus entry and exit; however, he also has active research projects on innate immunity, viral translation, and vaccine development.
After completing his BSc in Virology at Warwick University, Dr. Bailey did his PhD on the neglected viral pathogen, peste des petits ruminants virus (PPRV) - the small ruminant morbillivirus - before spending 5 years as a postdoctoral researcher working on caliciviruses (murine norovirus and feline calicivirus) in the lab of Prof. Ian Goodfellow at Imperial College London. He has been a Principal Investigator since 2012 working firstly at the University of Birmingham and more recently at The Pirbright Institute, both in the UK.
Since the beginning of 2020, his lab has been involved in SARS-CoV-2 research, splitting its time between basic research on SARS-CoV-2 host range and supporting the development of COVID-19 vaccines. As part of the recently funded UKRI Genotype-to-Phenotype consortium his lab will continue to support SARS-CoV-2 research by helping in the phenotypic characterisation of genetic variants that emerge during the COVID-19 pandemic.
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Bailey, D. (2021, February 16). Interspecies transmission of SARS-CoV-2 [Audio file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/KUFB9037.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Dalan Bailey has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Other Talks in the Playlist: Interviews on Covid-19
Transcript
Quiz
Disclaimer: This quiz is intended for learning assessment purposes only and does not grant any certification or credit.
If you are interested in getting a certificate for watching the talk, follow the instructions in this talk's Accreditation Information (where available.)